
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel evidence for the prognostic impact of β-blockers in solid cancer patients receiving immune checkpoint inhibitors
Xuebing Yan, Peipei Liu, Donglin Li, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109383-109383
Closed Access | Times Cited: 12
Xuebing Yan, Peipei Liu, Donglin Li, et al.
International Immunopharmacology (2022) Vol. 113, pp. 109383-109383
Closed Access | Times Cited: 12
Showing 12 citing articles:
Variações na Captação de FDG Miocárdica e Uso de Metformina: Implicações para a Sobrevida Durante a Imunoterapia
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access | Times Cited: 1
Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
Rachel Massalee, Xuefang Cao
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Rachel Massalee, Xuefang Cao
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 6
Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications
Julien Colard‐Thomas, Quentin Dominique Thomas, Marie Viala
Cancers (2023) Vol. 15, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 11
Julien Colard‐Thomas, Quentin Dominique Thomas, Marie Viala
Cancers (2023) Vol. 15, Iss. 8, pp. 2276-2276
Open Access | Times Cited: 11
Variations in Myocardial FDG Uptake and Metformin Use: Implications for Survival during Immunotherapy
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access
Trial watch: beta-blockers in cancer therapy
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Killian Carnet Le Provost, Oliver Kepp, Guido Kroemer, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 10
Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors
Xuebing Yan, Jiaxin Wang, Jingxian Mao, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Xuebing Yan, Jiaxin Wang, Jingxian Mao, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 9
Impact of concomitant medications on the efficacy of immune checkpoint inhibitors: an umbrella review
Honglin Li, Lei Zhang, Feiran Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Honglin Li, Lei Zhang, Feiran Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Beta-Adrenergic Blockade in Advanced Non-Small Cell Lung Cancer Patients Receiving Immunotherapy: A Multicentric Study
Ana Duarte Mendes, Ana Rita Pinheiro de Freitas, Rodrigo Vicente, et al.
Cureus (2024)
Open Access | Times Cited: 3
Ana Duarte Mendes, Ana Rita Pinheiro de Freitas, Rodrigo Vicente, et al.
Cureus (2024)
Open Access | Times Cited: 3
Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study
Jiaxin Wang, Jie Lin, Huaijuan Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Jiaxin Wang, Jie Lin, Huaijuan Guo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Immune Checkpoint Inhibitors and the Exposome: Host-Extrinsic Factors Determine Response, Survival, and Toxicity
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Elio Gregory Pizzutilo, Rebecca Romanò, Laura Roazzi, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2283-2296
Open Access | Times Cited: 7
Personalized Immunotherapy of Patients: Defining by Single-cell RNA-seq with Artificial Intelligence
Yaqin Li
Medical Research Archives (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 2
Yaqin Li
Medical Research Archives (2023) Vol. 11, Iss. 8
Open Access | Times Cited: 2
Anti-hypertensives associated with survival in cancer patients receiving immunotherapy: new evidence from a real-world cohort study and meta-analysis
Ping Ma, Zhihuan Zhang, Mingyang Qian, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access
Ping Ma, Zhihuan Zhang, Mingyang Qian, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access